Related Experiment Video
Updated: Jul 5, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Image guidance based on prostate position for prostate cancer proton therapy
Carlos Vargas1, Marcus Wagner, Daniel Indelicato
1Department of Radiation Oncology, University of Florida Proton Therapy Institute, 2015 N. Jefferson Street, Jacksonville, FL 32206, USA. c2002@ufl.edu
Summary
Proton beam realignment significantly improves clinical target volume (CTV) coverage in prostate cancer patients. This technique enhances dose delivery accuracy, especially after prostate repositioning during proton therapy.
Area of Science:
- Radiation Oncology
- Medical Physics
- Prostate Cancer Treatment
Background:
- Proton therapy offers precise radiation delivery for prostate cancer.
- Accurate patient positioning is crucial for effective proton therapy.
- Image guidance and daily adjustments are essential to account for anatomical variations.
Purpose of the Study:
- To evaluate the impact of image guidance and daily pre-beam reorientation on target coverage in proton therapy for prostate cancer.
- To quantify the improvements in clinical target volume (CTV) coverage and dose delivery accuracy.
Main Methods:
- Analysis of 207 prostate positions from 9 prostate cancer patients undergoing proton therapy.
- Definition of planning target volume (PTV) including prostate and margins.
- Simulated prostate repositioning with 5-mm and 10-mm shifts and multidimensional movements.
- Beam realignment after simulated prostate shifts.
Main Results:
- Realignment improved CTV coverage and minimal dose for small (<=5 mm) and large (10 mm) prostate shifts.
- Significant dose improvements observed for anterior, posterior, inferior, and superior shifts.
- Compounded multidimensional shifts showed substantial gains in CTV V(78) (11.8%) and minimal dose (23.6 GE) after realignment.
- Post-realignment, CTV minimal dose exceeded 98% of the prescribed 78 GE for all analyzed points.
Conclusions:
- Proton beam realignment after target shifts enhances CTV coverage in prostate cancer patients.
- Daily pre-beam reorientation is a valuable tool for optimizing dose delivery in proton therapy.
- This technique improves treatment accuracy and potentially patient outcomes.

